Search hospitals > Kansas > Prairie Village
Collective Medical Research
Claim this profilePrairie Village, Kansas 66208
Global Leader in Migraine
Conducts research for Depression
Conducts research for Major Depressive Disorder
Conducts research for Compulsive Personality Disorder
Conducts research for Obsessive-Compulsive Disorder
18 reported clinical trials
1 medical researcher
Summary
Collective Medical Research is a medical facility located in Prairie Village, Kansas. This center is recognized for care of Migraine, Depression, Major Depressive Disorder, Compulsive Personality Disorder, Obsessive-Compulsive Disorder and other specialties. Collective Medical Research is involved with conducting 18 clinical trials across 16 conditions. There are 1 research doctors associated with this hospital, such as Mikel Thomas.Top PIs
Clinical Trials running at Collective Medical Research
Migraine
Depression
Compulsive Personality Disorder
Obsessive-Compulsive Disorder
Schizophrenia
Major Depressive Disorder
Anxiety
Generalized Anxiety Disorder
Rimegepant
for Migraine
This study is being conducted to evaluate the efficacy and tolerability of rimegepant in a population of adults that are unsuitable for triptan medications due to a previous intolerance, lack of efficacy, or contraindication (including a history of clinically-relevant cardiovascular disease).
Recruiting2 awards Phase 4
Ubrogepant
for Migraine
A migraine is a moderate to severe headache typically on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other symptoms. Menstrual migraine (MM) is defined as migraine attacks that occur within the perimenstrual period (PMP) in at least 2 out of 3 menstrual cycles. The PMP is from 2 days before the onset of menstrual bleeding to 2 days after. This study will assess how safe and effective ubrogepant is in treating menstrual migraine. Adverse Events and change in disease activity will be assessed. Ubrogepant is an investigational drug being developed for short-term prevention of menstrual migraine. Participants will be randomly assigned to one of the 2 groups to receive either ubrogepant or placebo. Around 450 adult female participants with menstrual migraine will be enrolled in approximately 85 sites in the United States and Puerto Rico. Participants will receive oral ubrogepant tablets once daily for 7 consecutive days starting 3 days prior to estimated onset of menses per cycle for 3 PMPs during double-blind period (16 weeks). Eligible participants may continue to receive oral ubrogepant tablets once daily for 7 consecutive days per cycle starting 3 days prior to estimated onset of menses during open-label extension period (52 weeks). There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will collect data daily in electronic diaries and attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
Recruiting1 award Phase 33 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Collective Medical Research?
Collective Medical Research is a medical facility located in Prairie Village, Kansas. This center is recognized for care of Migraine, Depression, Major Depressive Disorder, Compulsive Personality Disorder, Obsessive-Compulsive Disorder and other specialties. Collective Medical Research is involved with conducting 18 clinical trials across 16 conditions. There are 1 research doctors associated with this hospital, such as Mikel Thomas.